Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Josep Lloreta-Trull"'
Autor:
Albert Martin-Cardona, Josep Lloreta Trull, Raquel Albero-González, Marta Paraira Beser, Xavier Andújar, Pablo Ruiz-Ramirez, Jaume Tur-Martínez, Carme Ferrer, José Angel De Marcos Izquierdo, Anna Pérez-Madrigal, Laura Goiburú González, Jorge Espinós Perez, Maria Esteve
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background SARS-CoV-2 may produce intestinal symptoms that are generally mild, with a small percentage of patients developing more severe symptoms. The involvement of SARS-CoV-2 in the physiopathology of bowel damage is poorly known. Transmi
Externí odkaz:
https://doaj.org/article/014f1bba76fd4da68e6de6bea60ef328
Autor:
David J. Kwiatkowski, Gad Getz, Eliezer M. Van Allen, Henry W. Long, Paloma Cejas, Mary-Ellen Taplin, Kent W. Mouw, Silvia Hernandez, Josep Lloreta-Trull, Nuria Juanpere, Inés de Torres, Juan Morote, Justine A. Barletta, Michaela Bowden, Stephanie A. Wankowicz, Alejo Rodriguez-Vida, Anna Orsola, Júlia Perera-Bel, Brendan Reardon, Jaegil Kim, Joaquim Bellmunt
High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non–muscle-invasive bladder cancer with unpredictable outcome and poorly understood risk factors. Here, we examined the association of somatic mutation profiles with nonrecurrent di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106a3da1c4ae756831d98851315c327b
https://doi.org/10.1158/0008-5472.c.6512317
https://doi.org/10.1158/0008-5472.c.6512317
Autor:
David J. Kwiatkowski, Gad Getz, Eliezer M. Van Allen, Henry W. Long, Paloma Cejas, Mary-Ellen Taplin, Kent W. Mouw, Silvia Hernandez, Josep Lloreta-Trull, Nuria Juanpere, Inés de Torres, Juan Morote, Justine A. Barletta, Michaela Bowden, Stephanie A. Wankowicz, Alejo Rodriguez-Vida, Anna Orsola, Júlia Perera-Bel, Brendan Reardon, Jaegil Kim, Joaquim Bellmunt
Supplementary figures, tables, material & methods and results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045b5cee9881419085a776439fc4b154
https://doi.org/10.1158/0008-5472.22426366
https://doi.org/10.1158/0008-5472.22426366
Autor:
Silvia Hernández-Llodrà, Laura Segalés, Marta Lorenzo, Lluís Fumadó, Nuria Juanpere, Lluís Cecchini, Josep Lloreta-Trull, Adrià Lloret, Raquel Albero-González, Xavier Duran
Publikováno v:
Virchows Archiv. 475:223-231
The role of DNA MMR genes in prostate cancer (PrCa) is controversial, as genetic alterations leading to microsatellite instability are incompletely defined in these tumors. ERG rearrangements and PTEN loss are concomitant events in PrCa. The aim of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fa4dd91e7a6b47daea2a8b07d4f4fb6
https://doi.org/10.1007/s00428-019-02591-z
https://doi.org/10.1007/s00428-019-02591-z
Autor:
Lluís Cecchini, Tech David López, Lara Nonell, Silvia Hernández-Llodrà, Lluís Fumadó, Marta Salido, Laura Segalés, Joaquim Bellmunt, Alejo Rodriguez-Vida, Tech Marta Lorenzo, Josep Lloreta-Trull, Nuria Juanpere
Publikováno v:
The ProstateREFERENCES. 81(16)
Background: In the non-ETS fusion of prostate cancer (PCa) pathway, SPOP mutations emerge as a distinct oncogenic driver subclass. Both SPOP downregulation and mutation can lead to SPOP target stabilization promoting dysregulation of key regulatory p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e0792d211c12964b2e6fc1c02ad950
https://pubmed.ncbi.nlm.nih.gov/34533858
https://pubmed.ncbi.nlm.nih.gov/34533858
Autor:
Josep Lloreta-Trull, Mar Iglesias, Raúl Peña, Laura Comerma, Laura Palacios, Antonio García de Herreros, David Cabrerizo-Granados, Laura Carrillo-Bosch
Publikováno v:
Theranostics
Snail1 is a transcriptional factor required for epithelial to mesenchymal transition and activation of cancer-associated fibroblasts (CAF). Apart from that, tumor endothelial cells also express Snail1. Here, we have unraveled the role of Snail1 in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442fd5afccbc1232ea8250ca03c38239
http://hdl.handle.net/10230/52737
http://hdl.handle.net/10230/52737
Autor:
Juan Morote, Joaquim Bellmunt, Paloma Cejas, Silvia Hernández, Michaela Bowden, Kent W. Mouw, Inés de Torres, Justine A. Barletta, Alejo Rodriguez-Vida, Josep Lloreta-Trull, Gad Getz, Nuria Juanpere, Eliezer M. Van Allen, Mary-Ellen Taplin, David J. Kwiatkowski, Júlia Perera-Bel, Anna Orsola, Henry W. Long, Jaegil Kim, Stephanie A. Wankowicz, Brendan Reardon
Publikováno v:
Cancer Res
High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non–muscle-invasive bladder cancer with unpredictable outcome and poorly understood risk factors. Here, we examined the association of somatic mutation profiles with nonrecurrent di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4756cad605b99870c635b0568d7fb1e7
https://europepmc.org/articles/PMC9361191/
https://europepmc.org/articles/PMC9361191/
Autor:
Alba Dalmases, Ivonne Vazquez, Jessica Munné-Collado, Josep Lloreta Trull, Nuria Juanpere, Sergi Mojal, Silvia Hernández, Marta Salido, Lara Pijuan, Mercedes Simón, Javier Gimeno-Beltrán, Sergi Clavé, Álvaro Taus, Albert Sánchez-Font, Raquel Albero-González, Laura Comerma, Belen Lloveras
Publikováno v:
Ultrastructural pathology. 43(6)
With the identification of therapeutic targets for lung adenocarcinoma, it has become mandatory to distinguish it from other entities. Some cases remain classified as non-small cell lung carcinoma, not otherwise specified (NSCLC-NOS) with immunohisto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c64cd848cfd65b6c203e144de3c4933a
https://pubmed.ncbi.nlm.nih.gov/31810413
https://pubmed.ncbi.nlm.nih.gov/31810413
Autor:
Silvia Hernández-Llodrà, Lluís Fumadó, Laura Segalés, Lluís Cecchini, Nuria Juanpere, Joaquim Bellmunt, Josep Lloreta-Trull, Raquel Albero-González, Marta Lorenzo
Publikováno v:
Virchows Archiv : an international journal of pathology. 475(4)
Overexpression of ETS genes is involved in prostate cancer (PrCa), but there is little information on the non-ERG components of this family. We have investigated ETV1, ETV4, and ETV5 overexpression, with or without PTEN loss, and their association wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9a62d5ef7decdfa5e03550a29f153e
https://pubmed.ncbi.nlm.nih.gov/31016435
https://pubmed.ncbi.nlm.nih.gov/31016435
Autor:
Silvia, Hernández-Llodrà, Laura, Segalés, Ainara, Safont, Nuria, Juanpere, Marta, Lorenzo, Lluís, Fumadó, Alejo, Rodríguez-Vida, Lluís, Cecchini, Joaquim, Bellmunt, Josep, Lloreta-Trull
Publikováno v:
The Prostate. 79(10)
ERG fusion-related prostate cancer (PrCa) is the most prevalent oncogenic driver subclass. SPOP, FOXA1, and IDH1 mutations are other three main oncogenic driver subclasses in non-ETS-fusion PrCa. ERG protein levels seem to be increased in SPOP-mutate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f2cbaefbabca9e59847bf462ca054a4
https://pubmed.ncbi.nlm.nih.gov/31090082
https://pubmed.ncbi.nlm.nih.gov/31090082